How should ascites due to cirrhosis be diagnosed and managed?

Management of Ascites in Cirrhosis

All patients with new-onset ascites should undergo diagnostic paracentesis immediately to determine the cause (calculate SAAG) and rule out spontaneous bacterial peritonitis, followed by first-line treatment with dietary sodium restriction (≤2000 mg/day) and combination diuretic therapy with spironolactone 100 mg plus furosemide 40 mg daily, titrated upward as needed. 1, 2

Diagnostic Approach

Initial Paracentesis - Mandatory for All New Ascites

Perform diagnostic paracentesis in all patients with new-onset ascites, even without symptoms of infection 1. This is non-negotiable and should occur within 12-24 hours of hospital admission when applicable, as early paracentesis is associated with lower mortality 2.

Essential fluid analysis includes:

• Serum-Ascites Albumin Gradient (SAAG): Subtract ascitic fluid albumin from serum albumin
  • SAAG ≥1.1 g/dL confirms portal hypertension (cirrhosis)
  • SAAG <1.1 g/dL suggests non-portal hypertension causes (malignancy, tuberculosis, pancreatic disease) 1, 2
• Cell count with differential: Neutrophil count >250/mm³ diagnoses spontaneous bacterial peritonitis 1, 3
• Culture: Inoculate 10 mL into blood culture bottles at bedside before antibiotics 1, 3
• Total protein concentration 1

Additional testing (cytology, amylase, BNP, adenosine deaminase) should be ordered only when specific alternative diagnoses are suspected 1.

Repeat Paracentesis Indications

Perform diagnostic paracentesis on every hospital admission for cirrhotic patients with ascites, regardless of symptoms, due to high SBP risk 1, 3. Also perform when patients develop fever, abdominal pain, encephalopathy, GI bleeding, shock, worsening renal function, or any signs of systemic inflammation 1.

First-Line Treatment: Sodium Restriction + Diuretics

Dietary Sodium Restriction

Restrict sodium to ≤2000 mg/day (87-113 mmol/day), which translates to a no-added-salt diet with avoidance of processed foods 1, 2. Refer all patients to a dietitian for education on label reading and meal preparation 2.

Critical caveat: Do not restrict calories or protein—patients need ≥35 kcal/kg/day and 1.2-1.5 g/kg protein daily to prevent malnutrition 2. Fluid restriction is not necessary unless serum sodium drops below 120-125 mmol/L 4, 1.

Diuretic Therapy

For first presentation with moderate ascites: Start spironolactone monotherapy at 100 mg daily, increasing to maximum 400 mg daily 1.

For recurrent or severe ascites, or hospitalized patients needing faster diuresis: Use combination therapy from the start—spironolactone 100 mg plus furosemide 40 mg daily, maintaining the 100:40 ratio up to maximum doses of 400 mg:160 mg 1, 2. The 2021 BSG/BASL guidelines strongly recommend this combination approach as it enhances natriuresis while maintaining normokalemia and outperforms sequential therapy 2.

Dosing strategy: Give spironolactone once daily in the morning (long half-life) to avoid nocturia 2. Titrate doses upward every 3-5 days based on response 4.

Target weight loss:

• 0.5 kg/day in patients without peripheral edema
• 1.0 kg/day in patients with peripheral edema 2

Monitoring for Diuretic Complications

Monitor closely—almost half of patients develop adverse events requiring dose reduction or discontinuation 1. Check electrolytes, renal function, and clinical status regularly.

Management of hyponatremia during diuretic therapy:

• Serum Na 126-135 mmol/L with normal creatinine: Continue diuretics, monitor closely, no fluid restriction 5
• Serum Na 121-125 mmol/L with normal creatinine: Stop or reduce diuretics 5
• Serum Na 121-125 mmol/L with elevated creatinine (>150 μmol/L): Stop diuretics immediately, give volume expansion with colloid or saline 5
• **Serum Na <120 mmol/L**: Stop diuretics, volume expansion needed, but avoid increasing sodium >12 mmol/L per 24 hours 5
• Severe symptomatic hyponatremia: Reserve hypertonic saline (3%) only for severely symptomatic acute cases, correct slowly 1

Other complications requiring diuretic adjustment:

• Hepatic encephalopathy
• Serum creatinine >2.0 mg/dL
• Serum potassium >6.0 mmol/L 4

Avoid NSAIDs completely—they reduce urinary sodium excretion and can convert diuretic-sensitive patients to refractory ascites 4.

Large Volume Paracentesis

When to Perform Therapeutic Paracentesis

Perform initial therapeutic paracentesis for tense ascites causing respiratory compromise or significant discomfort, then initiate sodium restriction and oral diuretics 4, 1. The 2004 Hepatology guidelines emphasize that while large-volume paracentesis removes fluid faster than diuretics (minutes vs. days to weeks), it does nothing to correct the underlying sodium retention problem 4.

Key principle: In diuretic-sensitive patients, serial paracentesis when diuretics could control ascites is inappropriate 4. Diuretics should be the preferred maintenance therapy.

Paracentesis Technique and Safety

• Obtain informed consent 1
• Use ultrasound guidance when available to reduce complications 1
• Do not routinely check PT/INR or platelet count before paracentesis
• Do not transfuse blood products prophylactically before the procedure 1

Albumin Replacement After Paracentesis

For paracentesis >5 liters: Infuse albumin (20% or 25% solution) at 8 g per liter of ascites removed after paracentesis is completed 1. This is a strong recommendation with high-quality evidence to prevent post-paracentesis circulatory dysfunction 1.

For paracentesis <5 liters: Albumin replacement is not routinely required 4. However, consider albumin (8 g/L removed) in patients with acute-on-chronic liver failure (ACLF) or high risk of post-paracentesis acute kidney injury 1.

The 2004 guidelines note that synthetic plasma expanders (150-200 mL gelofusine or haemaccel) are acceptable alternatives for paracentesis <5 L 5.

Refractory Ascites

Definition

Refractory ascites is defined as fluid overload that either:

1. Fails to respond to sodium restriction and maximum diuretic doses (spironolactone 400 mg + furosemide 160 mg daily), with urinary sodium <78 mmol/day and minimal weight loss, OR
2. Recurs rapidly after therapeutic paracentesis, OR
3. Develops clinically significant diuretic complications (encephalopathy, creatinine >2.0 mg/dL, sodium <120 mmol/L, potassium >6.0 mmol/L) 4

Management Options for Refractory Ascites

Serial large-volume paracentesis: Effective for controlling ascites, typically needed every 2 weeks 4. Each 6-liter paracentesis removes approximately 780 mmol of sodium 4. Frequency of paracentesis provides insight into dietary compliance 4.

TIPSS (Transjugular Intrahepatic Portosystemic Shunt): Should be considered in all patients with refractory ascites 1. The 2021 BSG/BASL guidelines give this a strong recommendation with high-quality evidence 1. TIPSS eliminates ascites and improves renal function but requires careful patient selection 6.

Exercise caution with TIPSS in patients with:

• Age >70 years
• Serum bilirubin >50 μmol/L (approximately 3 mg/dL)
• Platelet count <75×10⁹/L
• MELD score ≥18
• Current hepatic encephalopathy
• Active infection
• Hepatorenal syndrome 1

The evidence shows TIPSS can worsen hepatic encephalopathy and cause cardiac decompensation, so cardiac evaluation is essential before insertion 6. Consider under-dilating the TIPSS initially and using rifaximin starting pre-TIPSS to reduce encephalopathy risk 6.

For patients unsuitable for TIPSS: Continue serial large-volume paracentesis or consider alfapump (automated low-flow ascites pump) for quality of life improvement, though this doesn't alter survival 6.

Spontaneous Bacterial Peritonitis (SBP)

Diagnosis

SBP is diagnosed when ascitic fluid neutrophil count exceeds 250/mm³, with or without positive culture 1, 3. Perform diagnostic paracentesis immediately on all hospitalized cirrhotic patients with ascites, even without infection symptoms 1, 3.

Treatment

Start empirical IV antibiotics immediately when neutrophil count >250/mm³, before culture results 3.

Antibiotic choice:

• Community-acquired SBP in areas with low MDRO prevalence: Cefotaxime 2 g IV every 12 hours (or ceftriaxone) 1, 3
• Nosocomial SBP, recent hospitalization, or critically ill patients: Use broader-spectrum antibiotics due to increasing multidrug-resistant organisms 3
• Choice should be guided by local resistance patterns 1

Albumin for SBP: In patients with SBP and elevated or rising serum creatinine, infuse 1.5 g albumin/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 1. This reduces mortality.

Consider repeat paracentesis at 48 hours if inadequate response or if secondary bacterial peritonitis is suspected 1.

SBP Prophylaxis

Primary prophylaxis: Offer to high-risk patients with ascitic protein <1.5 g/dL, though antibiotic choice should be guided by local resistance patterns 1. The 2021 guidelines note uncertainties about routine primary prophylaxis due to fluoroquinolone resistance and FDA warnings about serious side effects 1.

Secondary prophylaxis: Patients who survive SBP have a 70% recurrence rate at 1 year 1. Treat with norfloxacin 400 mg daily, ciprofloxacin 500 mg daily, or co-trimoxazole (800/160 mg daily) to prevent recurrence 1, 5. The 2021 guidelines give this a weak recommendation due to low-quality evidence 1.

GI bleeding prophylaxis: All cirrhotic patients with ascites presenting with GI bleeding should receive prophylactic antibiotics (cefotaxime widely studied, but choose based on local data) to prevent SBP 1. This is a strong recommendation with strong evidence 1.

Liver Transplantation

All patients with cirrhosis and ascites should be evaluated for liver transplantation 4, 1. Development of ascites marks hepatic decompensation and significantly worsens prognosis, with 50% mortality within 3 years 7. Transplantation should preferably occur before development of renal dysfunction 8.

Special Considerations

Hepatic hydrothorax: TIPSS should be considered after multidisciplinary team discussion 1. For patients not undergoing TIPSS or transplant evaluation, consider alternative palliative interventions 1.

Non-selective beta-blockers: Refractory ascites should not be viewed as a contraindication to beta-blockers 1. The evidence does not support routine discontinuation.

Umbilical hernia: Discuss suitability and timing of surgical repair with multidisciplinary team including physicians, surgeons, and anesthesiologists 1.

Palliative care: Patients with refractory ascites not undergoing transplant evaluation should be offered palliative care referral 1.